BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8497362)

  • 1. The prognostic value of hemoglobin A1c in predicting fetal heart disease in diabetic pregnancies.
    Shields LE; Gan EA; Murphy HF; Sahn DJ; Moore TR
    Obstet Gynecol; 1993 Jun; 81(6):954-7. PubMed ID: 8497362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal echocardiographic screening of diabetic pregnancies for congenital heart disease.
    Gladman G; McCrindle BW; Boutin C; Smallhorn JF
    Am J Perinatol; 1997 Feb; 14(2):59-62. PubMed ID: 9259899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Accuracy and Cost-Effectiveness of Selective Fetal Echocardiography for the Diagnosis of Congenital Heart Disease in Patients with Pregestational Diabetes Stratified by Hemoglobin A1c.
    Finneran MM; Ware CA; Kiefer MK; Buschur EO; Foy PM; Thung SF; Landon MB; Gabbe SG
    Am J Perinatol; 2019 Oct; 36(12):1216-1222. PubMed ID: 30991442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Importance of "Guidelines for performing fetal cardiac scan" in prenatal screening for fetal congenital heart disease].
    Xu Y; Hu YL; Ru T; Gu Y; Yang Y; Dai CY
    Zhonghua Fu Chan Ke Za Zhi; 2009 Feb; 44(2):103-7. PubMed ID: 19570419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal echocardiography at the time of the nuchal translucency scan.
    Lombardi CM; Bellotti M; Fesslova V; Cappellini A
    Ultrasound Obstet Gynecol; 2007 Mar; 29(3):249-57. PubMed ID: 17318942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of detailed fetal echocardiography as part of routine prenatal ultrasonographic screening on detection of congenital heart disease.
    Stümpflen I; Stümpflen A; Wimmer M; Bernaschek G
    Lancet; 1996 Sep; 348(9031):854-7. PubMed ID: 8826811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital Malformation Risk According to Hemoglobin A1c Values in a Contemporary Cohort with Pregestational Diabetes.
    Martin RB; Duryea EL; Ambia A; Ragsdale A; Mcintire D; Wells CE; Spong CY; Dashe JS; Nelson DB
    Am J Perinatol; 2021 Oct; 38(12):1217-1222. PubMed ID: 34087946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal detection of fetal anomalies in pregnancies complicated by insulin-dependent diabetes mellitus.
    Albert TJ; Landon MB; Wheller JJ; Samuels P; Cheng RF; Gabbe S
    Am J Obstet Gynecol; 1996 May; 174(5):1424-8. PubMed ID: 9065106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fetal echocardiography in diagnosing congenital heart disease prenatally: a multicenter clinical study].
    Zhu RY; Gui YH; Li LC; Chen RY; Sun L; Chang C
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):764-9. PubMed ID: 17229382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal echocardiography in gravidas with historic risk factors for congenital heart disease.
    Maher JE; Colvin EV; Samdarshi TE; Owen J; Hauth JC
    Am J Perinatol; 1994 Sep; 11(5):334-6. PubMed ID: 7993511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One year audit of a referral fetal echocardiography service.
    Wilson NJ; Allen BC; Clarkson PM; Knight DB; Roberts AB; Calder AL
    N Z Med J; 1994 Jul; 107(981):258-60. PubMed ID: 8022579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-trimester ultrasound detection of fetal heart anomalies: systematic review and meta-analysis.
    Karim JN; Bradburn E; Roberts N; Papageorghiou AT;
    Ultrasound Obstet Gynecol; 2022 Jan; 59(1):11-25. PubMed ID: 34369613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening fetal echocardiography in diabetic mothers with normal findings on detailed anatomic survey.
    Sekhavat S; Kishore N; Levine JC
    Ultrasound Obstet Gynecol; 2010 Feb; 35(2):178-82. PubMed ID: 20101639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should all pregnant diabetic women undergo a fetal echocardiography? A cost-effectiveness analysis comparing four screening strategies.
    Odibo AO; Coassolo KM; Stamilio DM; Ural SH; Macones GA
    Prenat Diagn; 2006 Jan; 26(1):39-44. PubMed ID: 16378332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expected probability of congenital heart disease and clinical utility of fetal echocardiography in pregnancies with pre-gestational diabetes.
    Nassr AA; El-Nashar SA; Shazly SA; White WM; Brost BC
    Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():121-5. PubMed ID: 27104489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic and frequency of fetal heart disease by echocardiography in pregnancies with high-risk factors].
    Hinojosa Cruz JC; Luis Miranda RS; Veloz Martínez MG; Puello Tamara E; Arias Monroy LG; Barra Urrutia A; Cetina Camara Ndel P; del Angel G; Gutiérrez González GA; Ramos García RA; Santos Vera I
    Ginecol Obstet Mex; 2006 Dec; 74(12):645-56. PubMed ID: 17539320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal echocardiography in Manitoba: a regional perspective.
    Ash K; Giddins N; Pelech A; Collins G
    Can J Cardiol; 1990 Nov; 6(9):396-8. PubMed ID: 2276075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is an isolated fetal cardiac echogenic focus an indication for fetal echocardiography?
    Barsoom MJ; Feldman DM; Borgida AF; Esters D; Diana D; Egan JF
    J Ultrasound Med; 2001 Oct; 20(10):1043-6. PubMed ID: 11587010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of congenital cardiac defects between 11 and 14 weeks' gestation in high-risk patients.
    Weiner Z; Lorber A; Shalev E
    J Ultrasound Med; 2002 Jan; 21(1):23-9. PubMed ID: 11794398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing the cost of detection of congenital heart disease in fetuses of women with pregestational diabetes mellitus.
    Bernard LS; Ramos GA; Fines V; Hull AD
    Ultrasound Obstet Gynecol; 2009 Jun; 33(6):676-82. PubMed ID: 19479684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.